Screening based on response surface methodology of multi-fractions traditional Chinese medicine with anti-influenza virus neuraminidase activity: Take Shuanghuanglian injection as an example

Yaoxue Xuebao

Volumn 47, Issue 4, 2012, Pages 466-471

  Qiu, Ling Ling ^a,b   Chen, Long Hu ^a,c   Yan, Dan ^a   Zhang, Ping ^a   Tan, Man Rong ^a,b   Li, Zheng Ming ^a   Xiao, Xiao He ^a  

^a 302 MILITARY HOSPITAL   (China)

^b JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Anti influenza neuraminidase activity; Multi fractions traditional Chinese medicine; Response surface methodology; Screening model; Shuanghuanglian injection

Indexed keywords

BAICALIN; CAFFEIC ACID; CHLOROGENIC ACID; SIALIDASE;

ACCURACY; ARTICLE; CHINESE MEDICINE; DRUG SCREENING; EXPERIMENT; INFLUENZA VIRUS; PREDICTION; RESPONSE SURFACE METHOD;

ANTIVIRAL AGENTS; CAFFEIC ACIDS; CHLOROGENIC ACID; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; FLAVONOIDS; INJECTIONS; MEDICINE, CHINESE TRADITIONAL; NEURAMINIDASE; ORTHOMYXOVIRIDAE;

EID: 84862236543     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fu JH, Fu Y, Liu JX, et al. The hypothesis of "component of pharmacy" [J]. Chin J Inf Tradit Chin Med 2006, 13: 52-54.
2. Liang XM, Xu Q, Xue XY, et al. System research components of traditional Chinese medicine [J]. World Sci Technol Mod Tradit Chin Med 2006, 8: 1-6.
3. Phillipson JD. Phytochemistry and medicinal plants [J]. Phytochemistry, 2001, 56: 237-243. (Pubitemid 32162796)
4. Phillipson JD. Phytochemistry and pharmacognosy [J]. Phytochemistry, 2007, 68: 2960-2972. (Pubitemid 350180942)
5. Xia XL, Jin HZ, Yan SK, et al. Analysis of the bioactive constituents of ChanSu in rat plasma by high performance liquid chromatography with mass spectrometric detection [J]. J Pharm Biomed Anal, 2010, 53: 646-654.
6. Wang BC, Zhu LC, Chen Q. Primary study on the application of serum pharmacology in Chinese traditional medicine [J]. Colloid Surface B, 2005, 43: 194-197.
7. Borisy AA, Elliott PJ, Hurst NW, et al. Systematic discovery of multicomponent therapeutics [J]. Proc Natl Acad Sci USA, 2003, 100: 7977-7982. (Pubitemid 36760080)
8. Ferreira SLC, Bruns RE, Ferreira HS, et al. Box-Behnken design: an alternative for the optimization of analytical methods [J]. Anal Chim Acta, 2007, 597: 179-186. (Pubitemid 47187836)
9. Macedo SM, Jesusa RM, Garciad KS, et al. Determination of total arsenic and arsenic (III) in phosphate fertilizers and phosphate rocks by HG-AAS after multivariate optimization based on Box-Behnken design [J]. Talanta, 2009, 80: 974-979.
10. Ragonese R, Macka M, Hughes J, et al. The use of the Box-Behnken experimental design in the optimisation and robustness testing of a capillary electrophoresis method for the analysis of ethambutol hydrochloride in a pharmaceutical formulation [J]. J Pharm Biomed Anal, 2002, 27: 995-1007. (Pubitemid 34142572)
11. Khajeh M, Sanchooli E. Optimization of microwave-assisted extraction procedure for zinc and iron determination in Celery by Box-Behnken design [J]. Food Anal Methods, 2010, 3: 75-79.
12. Lia M, Feng CP, Zhang ZY, et al. Optimization of process parameters for electrochemical nitrate removal using Box-Behnken design [J]. Electrochim Acta, 2010, 56: 265-270.
13. Huang S, Cha XQ, Luo JP, et al. Optimize of extraction of polysaccharides in Dendrobium by Box-Behnken method [J]. J Chin Med Mater 2007, 30: 591-594.
14. Ma W, Yi LF, Zhou JP, et al. Optimization of glycyrrhizic acid tablets prescription by Box-Behnken method [J]. Chin Tradit Herb Drug 2008, 39: 1486-1489.
15. China Pharmacopoeia Committee. Pharmacopoeia of the People's Republic of China [S]. 2010 ed. Vol. 1. Beijing: China Medical Science Press, 2010: 846-847.
16. Yan M, Sun ZL, Yang Q. Sensitivity analysis of reliability the method based on response surface [J]. Chin J Mech Engi 2007, 43: 67-71. (Pubitemid 350062951)
17. Bauer K, Richter M, Wutzier P, et al. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006 [J]. Antiviral Res, 2009, 82: 34-41.
18. Kalbfuss B, Knöchlein A, Kröber T, et al. Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity [J]. Biologicals, 2008, 36: 145-161. (Pubitemid 351508423)
19. Nayak DP, Reichl U. Neuraminidase activity assays for monitoring MDCK cell culture derived influenza virus [J]. J Virol Methods, 2004, 122: 9-15. (Pubitemid 39370044)
20. Potier M, Mameli L, Bélisle M, et al. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-D-N-acetylneuraminate) substrate [J]. Anal Biochem, 1979, 94: 287-296. (Pubitemid 9173017)
21. Cann AJ. Virus Culture: A Practical Approach [M]. Oxford: Oxford University Press, 1999: 1-60.
22. Li HB, Yan D, Wang JB, et al. The quality of the biological evaluation of Radix based on neuraminidase activity assay [J]. Acta Pharm Sin 2009, 44: 162-166.
23. Zu M, Zhou D, Gao L, et al. Evaluation of Chinese traditionnal patent medicines against influenza virus in vitro [J]. Acta Pharm Sin 2010, 45: 408-412.